AI Article Synopsis
- Screening for colorectal cancer with fecal occult blood tests (FOBT) is effective, but not completing repeat tests can lower its effectiveness.
- A systematic review analyzed studies from 1997 to 2017, focusing on participant completion rates of FOBT over multiple rounds, with a median completion rate of about 82% for the second round.
- The review found that repeat FOBT rates decreased in successive rounds, highlighting the need for interventions to boost participation and maintain the effectiveness of screening strategies.
Article Abstract
Screening with fecal occult blood tests (FOBT) reduces colorectal cancer mortality. Failure to complete repeat tests may compromise screening effectiveness. We conducted a systematic review of repeat FOBT across diverse health care settings. We searched MEDLINE, Embase, and the Cochrane Library for studies published from 1997 to 2017 and reported repeat FOBT over ≥2 screening rounds. Studies ( = 27 reported in 35 articles) measured repeat FOBT as (i) proportion of Round 1 participants completing repeat FOBT in Round 2; (ii) proportion completing two, consecutive FOBT; or (iii) proportion completing ≥3 rounds. Among those who completed FOBT in Round 1, 24.6% to 89.6% completed repeat FOBT in Round 2 [median: 82.0%; interquartile range (IQR): 73.7%-84.6%]. The proportion completing FOBT in two rounds ranged from 16.4% to 80.0% (median: 46.6%; IQR: 40.5%-50.0%), and in studies examining ≥3 rounds, repeat FOBT ranged from 0.8% to 64.1% (median: 39.2%; IQR: 19.7%-49.4%). Repeat FOBT appeared higher in mailed outreach (69.1%-89.6%) compared with opportunistic screening (24.6%-48.6%). Few studies examined correlates of repeat FOBT. In summary, we observed a wide prevalence of repeat FOBT, and prevalence generally declined in successive screening rounds. Interventions that increase and maintain participation in FOBT are needed to optimize effectiveness of this screening strategy.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7007334 | PMC |
| http://dx.doi.org/10.1158/1055-9965.EPI-19-0775 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
On repeated diagnostic testing in screening for a medical condition: How often should the diagnostic test be repeated?
Biom J
April 2024
Mathematical Sciences and Southampton Statistical Sciences Research Institute, University of Southampton, Southampton, UK.
In screening large populations a diagnostic test is frequently used repeatedly. An example is screening for bowel cancer using the fecal occult blood test (FOBT) on several occasions such as at 3 or 6 days. The question that is addressed here is how often should we repeat a diagnostic test when screening for a specific medical condition.
View Article and Find Full Text PDFProjected Colorectal Cancer Incidence and Mortality Based on Observed Adherence to Colonoscopy and Sequential Stool-Based Screening.
Am J Gastroenterol
July 2024
Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Introduction: Modeling supporting recommendations for colonoscopy and stool-based colorectal cancer (CRC) screening tests assumes 100% sequential participant adherence. The impact of observed adherence on the long-term effectiveness of screening is unknown. We evaluated the effectiveness of a program of screening colonoscopy every 10 years vs annual high-sensitivity guaiac-based fecal occult blood testing (HSgFOBT) using observed sequential adherence data.
View Article and Find Full Text PDFAdaptation of Clinical Practice Guideline for Colorectal Cancer Screening in People with Average Risk in Isfahan Province.
Int J Prev Med
October 2022
Isfahan Gastroenterology and Hepatology Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Background: Colorectal cancer (CRC) is the third most common cancer among adults in Iran. The aim of colorectal cancer screening is to reduce the cancer burden in the population by diagnosing the disease in its early stages.
Methods: We adapted this guideline for the moderate CRC risk population for Isfahan to determine how to screen them and when to start and end the CRC screening.
A Systematic Review of Repeat Fecal Occult Blood Tests for Colorectal Cancer Screening.
Cancer Epidemiol Biomarkers Prev
February 2020
Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, Texas.
Article Synopsis
- Screening for colorectal cancer with fecal occult blood tests (FOBT) is effective, but not completing repeat tests can lower its effectiveness.
- A systematic review analyzed studies from 1997 to 2017, focusing on participant completion rates of FOBT over multiple rounds, with a median completion rate of about 82% for the second round.
- The review found that repeat FOBT rates decreased in successive rounds, highlighting the need for interventions to boost participation and maintain the effectiveness of screening strategies.
Perceived life expectancy and colorectal cancer screening intentions and behaviour: A population-based UK study.
Prev Med Rep
December 2019
Department of Behavioural Science and Health, University College London, Gower Street, London WC1E 6BT, United Kingdom.
The relationships between perceived life expectancy (PLE), cancer screening intentions and behaviour are not well understood, despite the importance of remaining life expectancy for the early diagnosis benefits of screening. This study investigates the relationships between PLE and each of: the intention to complete faecal occult blood test (FOBt) screening, 'ever' uptake of FOBt screening, and repeat uptake of FOBt screening for colorectal cancer. Data were from the population-representative Attitudes, Behaviour and Cancer UK Survey II (ABACUS II) in England in 2015.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!